Your browser doesn't support javascript.
loading
An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands.
Boersma, Cornelis; Carides, George W; Atthobari, Jarir; Voors, Adriaan A; Postma, Maarten J.
Afiliación
  • Boersma C; Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands. Electronic address: c.boersma@rug.nl.
  • Carides GW; Merck Research Laboratories, North Wales, Pennsylvania, USA.
  • Atthobari J; Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.
  • Voors AA; Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
  • Postma MJ; Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.
Clin Ther ; 29(5): 963-971, 2007 May.
Article en En | MEDLINE | ID: mdl-17697915

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atenolol / Hipertrofia Ventricular Izquierda / Losartán / Hipertensión / Antihipertensivos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Health_economic_evaluation / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Ther Año: 2007 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atenolol / Hipertrofia Ventricular Izquierda / Losartán / Hipertensión / Antihipertensivos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Health_economic_evaluation / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Ther Año: 2007 Tipo del documento: Article